GFOD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. GFOD Gen Silencer sind erhältlich als GFOD CRISPR/Cas9 Knockout Plasmide und GFOD Double Nickase Plasmide. GFOD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
GFOD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
GFOD1 CRISPR/Cas9 KO Plasmid (h) | sc-412277 | h | Gene Knockout | GFP | 0 | ||
GFOD1 HDR Plasmid (h) | sc-412277-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
GFOD1 Double Nickase Plasmid (h) | sc-412277-NIC | h | Gene Knockout | Puromycin | 0 | ||
GFOD1 Double Nickase Plasmid (h2) | sc-412277-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
GFOD1 CRISPR/Cas9 KO Plasmid (m) | sc-435887 | m | Gene Knockout | GFP | 0 | ||
GFOD1 HDR Plasmid (m) | sc-435887-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
GFOD1 Double Nickase Plasmid (m) | sc-435887-NIC | m | Gene Knockout | Puromycin | 0 | ||
GFOD1 Double Nickase Plasmid (m2) | sc-435887-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
GFOD2 CRISPR/Cas9 KO Plasmid (h) | sc-413437 | h | Gene Knockout | GFP | 0 | ||
GFOD2 HDR Plasmid (h) | sc-413437-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
GFOD2 Double Nickase Plasmid (h) | sc-413437-NIC | h | Gene Knockout | Puromycin | 0 | ||
GFOD2 Double Nickase Plasmid (h2) | sc-413437-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
GFOD2 CRISPR/Cas9 KO Plasmid (m) | sc-427748 | m | Gene Knockout | GFP | 0 | ||
GFOD2 HDR Plasmid (m) | sc-427748-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
GFOD2 Double Nickase Plasmid (m) | sc-427748-NIC | m | Gene Knockout | Puromycin | 0 | ||
GFOD2 Double Nickase Plasmid (m2) | sc-427748-NIC-2 | m | Gene Knockout | Puromycin | 0 |
GFOD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
GFOD1 CRISPR Activation Plasmid (h) | sc-412277-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 CRISPR Activation Plasmid (h2) | sc-412277-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 Lentiviral Activation Particles (h) | sc-412277-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 Lentiviral Activation Particles (h2) | sc-412277-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 CRISPR Activation Plasmid (m) | sc-435887-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 CRISPR Activation Plasmid (m2) | sc-435887-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 Lentiviral Activation Particles (m) | sc-435887-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD1 Lentiviral Activation Particles (m2) | sc-435887-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 CRISPR Activation Plasmid (h) | sc-413437-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 CRISPR Activation Plasmid (h2) | sc-413437-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 Lentiviral Activation Particles (h) | sc-413437-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 Lentiviral Activation Particles (h2) | sc-413437-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 CRISPR Activation Plasmid (m) | sc-427748-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 CRISPR Activation Plasmid (m2) | sc-427748-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 Lentiviral Activation Particles (m) | sc-427748-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
GFOD2 Lentiviral Activation Particles (m2) | sc-427748-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |